Jennifer Anne Nicki

Title: Innovations by Jennifer Anne Nicki

Introduction

Jennifer Anne Nicki is a notable inventor based in Gales Ferry, Connecticut. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides and antigens related to human cytomegalovirus (CMV). With a total of three patents to her name, her work has implications for medical research and therapeutic applications.

Latest Patents

Jennifer's latest patents focus on the human cytomegalovirus glycoprotein B (gB). One of her inventions involves polypeptides and CMV antigens that include at least two introduced amino acid mutations relative to the wild-type HCMV glycoprotein B. These polypeptides are stabilized in a conformation alternative to the gB postfusion conformation. Another patent comprises mutants of the wild-type CMV glycoprotein B protein, which also includes at least two introduced amino acid mutations. These compositions and their uses are crucial for advancing our understanding of CMV and developing potential treatments.

Career Highlights

Jennifer is currently employed at Pfizer Corporation, where she continues to innovate and contribute to the field of virology. Her work at Pfizer has allowed her to collaborate with leading experts in the industry and further her research on CMV.

Collaborations

Some of her notable coworkers include Yuhang Liu and Xiaoyuan Sherry Chi. Their collaborative efforts have enhanced the research environment and fostered innovation within their projects.

Conclusion

Jennifer Anne Nicki's contributions to the field of biotechnology, particularly in relation to human cytomegalovirus, highlight her role as a significant inventor. Her patents and ongoing work at Pfizer Corporation demonstrate her commitment to advancing medical research and therapeutic solutions.